Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An **endoglycosidase** is a type of enzyme that hydrolyzes internal glycosidic bonds in the oligosaccharide chains of glycoproteins or glycolipids, thereby releasing intact oligosaccharides from their protein or lipid backbones[1][5]. They are classified as glycosidases, and distinguish themselves from exoglycosidases by cleaving within the chain, rather than at terminal residues. Commonly studied endoglycosidases include Endoglycosidase H, Endoglycosidase S, and Peptide:N-glycanase (PNGase F). In biomedical research, endoglycosidases are important reagents for studying glycoprotein biochemistry, protein trafficking through the secretory pathway, and glycoengineering[2][3][6][7]. Endoglycosidases are not typically therapeutically targeted in human disease, but have high value in diagnostics, protein engineering, and biotechnology. The precise substrate specificity varies between different endoglycosidases and some (such as Endoglycosidase S) display exceptional specificity (e.g., IgG Fc N-glycans[3][4]), while others (such as PNGase F) act more broadly[7]. Endoglycosidases have been identified in bacteria, plants, and animals, including humans[5]. **Clarification/Correction:** There is something potentially incorrect or imprecise with targeting "Endoglycosidase" as a singular, canonical molecular entity because it refers to a broad enzyme class rather than a unique protein, receptor, or therapeutically actionable molecular target; **specific endoglycosidases (e.g., Endoglycosidase H, Endoglycosidase S, PNGase F, etc.) should be defined individually for structured information as therapeutic or diagnostic targets**[1][7][2][3][4].
Enzymatic cleavage of internal glycosidic linkages in oligosaccharides attached to proteins or lipids, releasing oligosaccharides from glycoproteins or glycolipids[1][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endoglycosidase.